Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,177 | -30,696 | -118,513 | -86,176 | -58,144 |
| Depreciation Amortization | 47 | 42 | 1,934 | 1,239 | 821 |
| Accounts receivable | N/A | 1,096 | 436 | -1,277 | -6,788 |
| Other Working Capital | 4,124 | -4,885 | 10,275 | 208 | -4,535 |
| Other Operating Activity | 189 | 3,990 | 13,790 | 11,298 | 13,583 |
| Operating Cash Flow | $-6,817 | $-30,453 | $-92,078 | $-74,708 | $-55,063 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 26,787 | 45,836 | 73,989 | 50,511 |
| PPE Investments | N/A | -836 | -2,375 | -323 | N/A |
| Investing Cash Flow | $N/A | $25,951 | $43,461 | $73,666 | $50,511 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | N/A | 1,677 | 1,676 | 560 |
| Other Financing Activity | 0 | -685 | 36,474 | 0 | 0 |
| Financing Cash Flow | $5 | $-685 | $38,151 | $1,676 | $560 |
| Beginning Cash Position | 22,919 | 53,683 | 64,149 | 64,149 | 64,149 |
| End Cash Position | 16,107 | 48,496 | 53,683 | 64,783 | 60,157 |
| Net Cash Flow | $-6,812 | $-5,187 | $-10,466 | $634 | $-3,992 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,817 | -30,453 | -92,078 | -74,708 | -55,063 |
| Capital Expenditure | N/A | -836 | -2,375 | -323 | N/A |
| Free Cash Flow | -6,817 | -31,289 | -94,453 | -75,031 | -55,063 |